Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme

NCT01752491 is registered in ClinicalTrials.gov with Joseph J. Cullen, MD, FACS as lead sponsor.

NCT NCT01752491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01752491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
Lead sponsor
Joseph J. Cullen, MD, FACS
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2013
Completion date
November 15, 2019
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gbm, glioblastoma, glioblastoma multiforme